In vitro diagnostic medical device through a Point of Care (PoC) system.
The KERASTOP project aims to develop the first clinical test based on scientific evidence for early diagnosis of Keratoconus, a degenerative pathology of the cornea. The innovation of the project consists on the development of a new in vitro diagnostic medical device (IVDD) through a Point of Care system.
The new medical device has been designed for an efficient, rapid, in situ and early detection of the two biomarkers associated with keratoconus, in patients who are candidates for laser refractive surgery.
Eurecat participates in the project through its Functional Printing and Embedded Devices Unit, which develops research and innovation in the project’s specialty fields; the eHealth Unit, that participates in tasks related with Artificial Intelligence and finally, the Product Development Unit, which participates in all the activities implied in the design of the device promoted by the project.
KERASTOP counts with the participation of a consortium led by the Cornea project company, an expert in corneal ocular pathologies.
General details
Project
KERASTOP – Disruptive molecular diagnostic for risk mitigation in refractive surgery
Project reference
RTC2019-007303-1
Programme and call for tender
Project financed by the Ministry of Science and Innovation and by the European Union, within the framework of the call Retos-Collaboration of the State Program of Research, Development and Innovation Oriented to the Challenges of Society, within the State Research Plan Scientific and Technical and Innovation 2017-2020, with the main objective of promoting technological development, innovation and quality research.
More information
